Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-24-000101
Filing Date
2024-04-15
Accepted
2024-04-15 13:34:55
Documents
41
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0415form10k.htm   iXBRL 10-K 306979
2 EXHIBIT 31.1 skin0415form10kexh31_1.htm EX-31.1 8244
3 EXHIBIT 31.2 skin0415form10kexh31_2.htm EX-31.2 8263
4 EXHIBIT 32.1 skin0415form10kexh32_1.htm EX-32.1 3978
10 GRAPHIC auditorheader.jpg GRAPHIC 5115
11 GRAPHIC image_001.jpg GRAPHIC 7596
  Complete submission text file 0001554795-24-000101.txt   1558416

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE skin-20231231.xsd EX-101.SCH 13873
6 XBRL CALCULATION FILE skin-20231231_cal.xml EX-101.CAL 21334
7 XBRL DEFINITION FILE skin-20231231_def.xml EX-101.DEF 13757
8 XBRL LABEL FILE skin-20231231_lab.xml EX-101.LAB 113770
9 XBRL PRESENTATION FILE skin-20231231_pre.xml EX-101.PRE 84517
45 EXTRACTED XBRL INSTANCE DOCUMENT skin0415form10k_htm.xml XML 97327
Mailing Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111
Business Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111 801-323-2395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 24844083
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)